scispace - formally typeset
A

Anthony Ogawa

Researcher at Merck & Co.

Publications -  27
Citations -  1068

Anthony Ogawa is an academic researcher from Merck & Co.. The author has contributed to research in topics: Glycogen phosphorylase & Mineralocorticoid receptor. The author has an hindex of 12, co-authored 27 publications receiving 977 citations.

Papers
More filters
Journal ArticleDOI

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).

TL;DR: A binding assay is developed and shown that labeled ezetimibe glucuronide binds specifically to a single site in brush border membranes and to human embryonic kidney 293 cells expressing NPC1L1, which unequivocally establish NPC1 L1 as the direct target of ezETimibe and should facilitate efforts to identify the molecular mechanism of cholesterol transport.
Journal ArticleDOI

Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.

TL;DR: The synthesis of a series of novel dihdyropyridine diacid glycogen phosphorylase inhibitors is presented and SAR and functional assay data are discussed, along with the effect of a single inhibitor on blood glucose in a diabetic animal model.
Journal ArticleDOI

Novel 3,4-Dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a

TL;DR: The preparation of a series of substituted indoles coupled to six- and seven-membered cyclic lactams is described and their role as human glycogen phosphorylase a inhibitors discussed and the SAR of the indole moiety and lactam ring are presented.
Patent

Mineralocorticoid receptor antagonists

TL;DR: In this paper, the compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, which are useful for treating aldosterone-mediated diseases, are disclosed.